Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 2 hours ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR5747Referred to Committee

Preventing Illegal Laboratories and Protecting Public Health Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-10-14
Introduced
6
Cosponsors
HR
ⓘ
Type

Sponsor

Jim Costa
Jim Costa
Democrat · CA · Representative
Votes with party: 90.2% (645 recorded votes)

Full profile: /officials/C001059

Source: Congress.gov · FEC

Cosponsors (6)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • David G. Valadao (R-CA-22)Original· 2025-10-14
  • Kevin Kiley (R-CA-3)· 2025-10-21
  • Vince Fong (R-CA-20)· 2025-12-05
  • Susie Lee (D-NV-3)· 2026-02-04
  • Dina Titus (D-NV-1)· 2026-02-09
  • Brian K. Fitzpatrick (R-PA-1)· 2026-04-09

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-10-14

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2025-10-14

Previously

  • Energy and Commerce CommitteeReferred To · 2025-10-14

Plain-English Summary

This bill would crack down on illegal drug manufacturing operations by strengthening enforcement against clandestine labs that produce dangerous substances like methamphetamine and fentanyl, protecting communities from the environmental contamination and public health risks these operations create. The legislation likely increases penalties for operating unlicensed labs, improves law enforcement tools to detect and shut down these facilities, and may provide resources for cleaning up contaminated sites left behind by illegal drug producers.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR10772Frontline Innovation Act
    Referred to Committee · 2026-10-09
  • HRES1611Expressing support for the designation of October 8, 2026, as "National Hydrogen and Fuel Cell Day".
    Referred to Committee · 2026-10-05
  • HRES1356A resolution commemorating the Day of Portugal, Camões, and the Portuguese Communities, and for other purposes.
    Referred to Committee · 2026-06-10
  • HRES1190Supporting the designation of April 19 through April 25, 2026, as "National Crime Victims' Rights Week".
    Referred to Committee · 2026-04-20